April 27, 2018
1514 Jefferson Hwy New Orleans, LA 70121 United States
At the World Symposium on Pulmonary Hypertension, industry leaders reviewed the progress that has been made in the diagnosis and treatment of pulmonary hypertension, redefined the classification of Pulmonary Hypertension, and formulated proposals for areas of future research. It was determined that multidisciplinary, multicenter collaborative efforts will lead to improved treatment for all patients with PH.
Although the tools used to diagnose PH have improved, the number and complexity of therapeutic options have made it challenging to predict prognosis. What is clear is that prompt diagnosis, assessment of severity of disease and initiation of appropriate therapy impact survival. Unfortunately, patients have symptoms for approximately 2.4 years before the diagnosis is made, reflecting a knowledge gap in the community which affects both patient morbidity and mortality. This CME event is meant to educate referring physicians in the Gulf South and hopefully reduce the time to diagnosis and treatment in patients with Pulmonary Arterial Hypertension.
Murali Chakinala, MD
Washington University St Louis
Wesley McConnell, MD
Kentuckiana Pulmonary Associates
Lana Melendres-Groves, MD
University of New Mexico
Fernando Torres, MD
University of Texas Southwestern
Contact Information: Kristin Tschirn Director email@example.com